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Objective: Diffuse pleural thickening (DPT)  refers to 
extensive visceral pleural fibrosis with adhesion forma-
tion to the parietal pleura obliterating the pleural space. 
The radiological definition of DPT remains controversial 
with most of the literature requiring the presence of an 
obliterated costophrenic angle (CPA)  for defining DPT. 
We conducted a study to investigate the variable distri-
butions of DPT and associated lung function deficit.
Methods: 85 patients referred to a pleural clinic with 
suspected pleural thickening were screened for our 
study. Data were collected from 37 patients with DPT 
confirmed on CT by size criteria (≥3 mm thick, ≥5 cm 
wide and ≥8 cm in length), and 21 controls with pleural 
plaques but no other pleuroparenchymal pathology. 27 
patients were excluded. Groups were matched to age, 
body mass index and smoking history.
Results: The percentage  of predicted forced vital 
capacity showed a gradual decline from 98.9% for the 
control group to 83.5% in the DPT without CPA oblite-
ration group (p < 0.05), to 79.5% in the unilateral DPT 
group (p < 0.001) and 66.7% in the bilateral group (p < 
0.001). Similar reductions were seen in the percentage 
of predicted total lung capacity in the DPT with no CPA 
obliteration group and the bilateral DPT group.
Conclusion: Our study shows an incremental reduction 
in the forced vital capacity and total lung capacity in 
DPT without CPA obliteration, unilateral and bilateral 
DPT when compared with a matched control group.
Advances in knowledge: Different distributions of 
DPT including no CPA obliteration can cause respira-
tory impairment, with bilateral DPT being the worst 
affected.
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inTRODuCTiOn
Diffuse pleural thickening (DPT) refers to extensive fibrosis 
of the visceral pleura with frequent adhesions to the pari-
etal pleura, leading to obliteration of the pleural space.1 It 
is usually the sequel to an exudative effusion and develops 
in approximately 7% of those with historical asbestos 
exposure.2,3
Unfortunately, there is still no universally accepted 
radiological definition for DPT. The International 
Labour Organization (ILO)4 bases their definition 
on obliteration of the costophrenic angle (CPA)  by 
pleural thickening on a postero-anterior chest radio-
graph, and this definiton  has been incorporated into 
the American Thoracic Society guidelines on diagnosis 
and initial management of non-malignant diseases 
related to asbestos.5 However, this definition  ignores 
the gold-standard imaging modality for assessing the 
pleura—CT. Many authorities cite the definition of DPT 
on CT proposed by Lynch et al based on size criteria as 
continuous thickening of the pleura measuring ≥5 cm 
wide, ≥8 cm long craniocaudally and 3 mm in thickness, 
with or without CPA involvement.6 Regardless of the 
radiological definition, the important clinical implication 
of DPT is that it frequently leads to significant respira-
tory disability1,7,8 and, when related to asbestos exposure, 
is currently recognized as a compensable disease under 
the Industrial Injuries Disablement Benefit scheme in 
the UK.9
Our aim was to evaluate the impact of DPT defined by CT 
and correlate its distribution, specifically involvement of 
CPA, with chest radiographic findings and contempora-
neous lung function testing.
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MeThODs AnD MATeRiAls
Data were collected from patients with suspected pleural thick-
ening referred to a dedicated pleural clinic at a single UK centre, 
between September 2011 and October 2016. All patients included 
had DPT by size criteria (≥3 mm depth, ≥5 cm axially and  ≥8 
cm craniocaudally), pleural thickening with tapered margins, 
pleuroparenchymal bands or rounded atelectasis on CT, and had 
contemporaneous chest X-ray and lung function. The study was 
approved by the Southwest Research Ethics Committee.
Data collected included patient demographics, asbestos expo-
sure history including duration and level of exposure, smoking 
history and other comorbidities. Patients with breathlessness 
had their degree of breathlessness documented against the 
Medical Research Council dyspnoea score, where a score of 
1 = not troubled by breathlessness except on strenuous exercise; 
2 = short of breath when hurrying on a level or when walking up 
a slight hill; 3 = walks slower than most people on the level, stops 
after a mile or so or stops after 15 min walking at own pace; 4 = 
stops for breath after walking 100 yards or after a few minutes on 
level ground; 5 = too breathless to leave the house or breathless 
when dressing/undressing.
CT scans
The CT scans were performed for clinical reasons using a range of 
multislice detector CT scanners (GE HD750 FREEdom Edition; 
GE Optima-General Electric, Boston, MA; Toshiba Aquilion CX; 
Toshiba, Tokyo, Japan; Philips Ingenuity; Phillips, Eindehoven, 
Netherlands). Standard departmental protocols were used with 
volumetric datasets acquired with or without contrast as indi-
cated clinically. All datasets were available with orthogonal 
isotropic reconstructions at 1–1.25 mm collimation using soft-
tissue and lung algorithms.
Lung function tests
All patients included in the study had full lung function tests, 
which included spirometry, lung volumes (by helium dilu-
tion and body plethysmography) and gas transfer (single-
breath carbon monoxide diffusing capacity). All patients had 
their height and weight recorded at the time of their lung 
function test. Lung function tests within 12 months of the 
CT scan were used for analysis. Lung function testing was 
performed using the  nSpire  Health  HDPFT  3000  (plethys-
mography  and  fast  gas  analyser)  (nSpire  Health  Ltd,  Hert-
ford, UK) and Collins CPL (helium dilution and gas transfer). . 
Lung function indices were expressed as a percentage of predicted 
and standardized residual values. Predicted values were Euro-
pean reference values.
Control group
The control group comprised patients who were referred to the 
pleural clinic and were found to have asbestos-related discrete 
pleural plaques only. Patients in this group were matched for age, 
body mass index (BMI) and smoking status, to the DPT group.
Radiology review
Two experienced chest radiologists (with a collective experi-
ence of 34 years) independently reviewed all CT scans and chest 
radiographs. CT images were reviewed with orthogonal refor-
matted data and electronic callipers on a soft tissue algorithm 
using standard mediastinal window settings (40/400). Diffuse 
pleural thickening was assessed according to Lynch’s size criteria 
whereby to qualify as DPT the thickening needed to be more than 
3 mm in thickness, 5 cm in width on axial CT slices and 8 cm in 
length craniocaudally. In addition to the size criteria, DPT was 
characterized morphologically by its tapered margin and ancillary 
signs of visceral pleural fibrosis, namely the presence of adjacent 
folded lung or pleuroparenchymal bands.10,11 These additional CT 
criteria were applied in order to exclude patients with large areas 
of confluent discrete plaques. The plain chest radiographs or CT 
scanograms were assessed for CPA obliteration and when present 
classified as unilateral (side specified) or bilateral.
Statistical analysis
Statistical analyses were carried out using the Stata statistical 
package, v. 14.2 (StataCorp  LLC, College  Station,  TX). Patient 
demographics such as age, BMI  and smoking history were 
expressed as means with standard deviations for each DPT 
group against the control group. Interobserver agreement when 
assessing chest radiographs and CT imaging was assessed using 
a weighted kappa coefficient. A p value less than 0.05 was consid-
ered statistically significant unless otherwise specified in the text. 
Distribution for normality was assessed using the Shapiro-Wilks 
test. Student’s t-test was used when comparing parametric data.
ResulTs
Eighty-five patients who were seen at the pleural clinic with 
suspected pleural thickening and or pleural plaques on their chest 
radiographs between September  2011 and October  2016 were 
included in the initial screening. Patients were excluded if they had 
significant pleural effusions at the time of the CT (n = 16), coexis-
tent interstitial pulmonary fibrosis (n = 5) or a subsequent diagnosis 
of pleural malignancy (n = 6). Fifty-eight patients (37 with DPT 
and 21 with pleural plaques alone) were then evaluated, including 
full pulmonary function testing (Figure 1).
The 37 patients who met DPT by CT size criteria were classified 
into three separate groups:
•	 Group 1: DPT by CT criteria with no CPA obliteration on chest 
radiograph
•	 Group 2: DPT by CT criteria with unilateral CPA obliteration 
on the chest radiograph
•	 Group 3: DPT by CT criteria with bilateral CPA obliteration on 
the chest radiograph.
An example chest radiograph and CT of a patient with right-
sided DPT but no CPA obliteration and bilateral DPT are shown 
in Figure 2.
Overall, there was good interobserver agreement on radiological 
findings. There was moderate agreement for CPA obliteration 
on chest  X-ray with a weighted kappa value of 0.79 and good 
agreement for DPT by size criteria on CT, with a weighted kappa 
value of 0.82. Discrepancies were resolved by consensus review 
of images.
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Figure 1. Flow diagram of total number of patients screened and reasons for exclusion. CPA, costophrenic angle; DPT, diffuse 
pleural thickening.
A summary demographics table, including the control group 
(pleural plaques only) is shown in Table  1. Fifty-six of the 
patients were male (97%), the mean age was 69.6 years (95% CI: 
67.3–71.9). The mean BMI was 29  kg m−2    (95%  CI: 28–30) 
and the average pack year history was 22.9 (95%  CI: 17.6–
28.2). There was no significant difference in the ages, BMI, 
Medical Research Council grade or pack year history of smoking 
between the subgroups.
Most patients (53/58) had clear documentation of the predom-
inant occupation that exposed them to asbestos    (Supplemen-
tary Table 1;  supplementary  material  available  online). The 
largest proportions exposed were in construction work (12.1%), 
civil engineering (8.6%) or heating and insulation engineering 
(8.6%). The miscellaneous group 15/58 (25.9%) included factory 
workers, a dockworker, ship plater and a chemistry teacher.
Seven (18.9%) patients in the DPT cohort had no pleural 
plaques on CT. Of these seven patients, two have had a 
previous coronary artery bypass graft and one had a history of 
an eosinophilic pleural effusion, which was documented as the 
cause of their pleural thickening. The other four patients had 
no pertinent past history such as causative drugs or previous 
pneumonic illnesses to explain their pleural thickening. These 
four patients’ occupations were construction work, kitchen 
fitting, electrical wholesale and labourer (involved in cleaning 
pipes lagged with asbestos).
Lung function parameters with their means and standard devi-
ations are shown in Table 2. The percentage of predicted forced 
vital capacity (FVC) showed a decline from 98.9% in the control 
group to 83.5% in the DPT with no CPA obliteration group 
(p = 0.045). Compared with the control group there were 
significant reductions in the FVC percentage of  predicted in 
the unilateral DPT group 79.5% (p < 0.001) and bilateral DPT 
group 66.7% (p < 0.001)   (Figures 3 and 4) . Similar differences 
are observed in the percentage of  predicted values for total 
lung capacity (TLC) between the control group (91.1%) and 
those with DPT without CPA obliteration (77.2%; p < 0.01) 
and the bilateral DPT group (66.7%; p < 0.001)  (Figures 5 and 
6). However, this relationship is lost between the control group 
and the unilateral DPT group.
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Figure 2. (a) Postero-anterior chest radiograph of a patient with right-sided diffuse pleural thickening (DPT) with no costophrenic 
angle obliteration. (b) Sagittal CT view of the same patient showing DPT involving the posterior pleura. (c) Patient with bilateral 
DPT and costophrenic angle obliteration. (d) Axial CT image confirming bilateral pleural thickening.
Table 1. Demographics by patient group
Demographic Control group (n = 21) 
No CPA 
obliteration (n = 10) 
Unilateral 
DPT (n = 15) 
Bilateral 
DPT (n = 12) p-Value 
Age (years)a 69.4 (65.7–73.1) 69.5 (64.9–74.0) 70.2 (65.0–75.5) 69.0 (62.0–76.1) 0.99 
BMI (kg m−2)a 28.2 (26.6–29.9) 30.5 (27.4–33.6) 28.7 (27.1–30.3) 29.4 (26.6–32.2) 0.45 
MRC gradea 3.5 (2.9–4.2) 3.9 (2.8–5.0) 3.4 (3.5–4.3) 4.6 (3.6–5.6) 0.20 
Comorbidities                
  COPD 4/21 (19%) 2/10 (20%) 3/15 (20%) 3/12 (25%)   
  CABG 1/21 (5%) 1/10 (10%) 4/15 (27%) 2/12 (17%) 
  Other 3/21 (14%) 0 3/15 (20%) 1/12 (8%) 
  Nil 13/21 (62%) 8/10 (80%) 5/15 (33%) 6/12 (50%) 
Smoking history (pyrs)a 20.5 (9.8–31.2) 24.2 (11.7–36.7) 22.4 (12.6–32.2) 27.0 (13.9–40.0) 0.85 
  Current smoker 2/21 (9%) 1/10 (10%) 2/14 (14%) 4/11 (36%) 
  Ex-smoker 13/21 (62%) 8/10 (80%) 10/14 (72%) 5/11 (46%) 
  Never smoker 6/21 (29%) 1/10 (10%) 2/14 (14%) 2/11 (18%) 
BMI, body mass index; CABG, coronary artery bypass graft; CI, confidence interval; COPD, chronic obstructive pulmonary disease; CPA, costophrenic 
angle; DPT, diffuse pleural thickening; MRC, Medical Research Council; pyrs, pack years.
aValues in parentheses are the 95% CIs.
5 of 7 birpublications.org/bjr Br J Radiol;90:20170218
BJRFull paper: Physiological consequences of DPT
Table 2. Mean and standard deviations for lung function parameters
Parameter Control group(n = 21) 
DPT but no CPA 
involvement (n = 10) 
Unilateral DPT 
(n = 15) 
Bilateral 
DPT (n = 12) 
FEV1 (L) 2.5 ± 0.6 2.1 ± 0.5 1.9 ± 0.5 1.7 ± 0.4 
FEV1 % predicted 86.9 ± 19.3 72.0 ± 15.7 65.7 ± 17.7 57.7 ± 10.0 
FVC (L) 3.8 ± 0.7 3.0 ± 0.9 3.0 ± 0.6 2.5 ± 0.8 
FVC % predicted 98.9 ± 15.2 83.5 ± 25.9 79.5 ± 13.0 66.7 ± 15.6 
FEV1/FVC ratio 68.1 ± 13.1 69.9 ± 13.9 63.9 ± 14.0 64.9 ± 11.8 
TLC (L) 6.2 ± 0.8 5.0 ± 0.9 5.4 ± 1.3 4.4 ± 0.6 
TLC % predicted 91.1 ± 9.4 77.2 ± 16.4 82.4 ± 20.8 66.6 ± 8.6 
TLCo % predicted 80.1 ± 23.3 62.8 ± 15.2 69.5 ± 17.5 61.4 ± 11.9 
KCO % predicted 92.9 ± 24.9 96 ± 17.2 102.5 ± 22.4 104.8 ± 22.0 
BMI 28.2 ± 3.6 31 ± 4.4 28.9 ± 2.8 28.5 ± 4.4 
BMI, body mass index; CPA, costophrenic angle; DPT, diffuse pleural thickening; FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity; 
KCO, diffusion coefficient; TLC, total lung capacity; TLCo, gas transfer.
Figure 3. Trend of percentage  of predicted FVC  by 
group. CPA, costophrenic angle; DPT, diffuse pleural thicken-
ing; FVC, forced vital capacity.
Figure 4. Mean FVC % predicted with confidence intervals
A scatter plot of the individual percentage of  predicted 
FVC and TLC values are shown in Figure 3 and 5.
DisCussiOn
To date, our study is the largest to examine the physiological 
impact of varied distributions of DPT using CT criteria and 
includes a significant number of patients in whom there is DPT 
without radiographic obliteration of the CPA on chest radio-
graph. Our data highlight the incremental deficit in lung function 
between bilateral DPT, unilateral DPT and DPT without radio-
graphic obliteration of the CPA compared with a control group 
with asbestos-related pleural plaques only. We demonstrate a 
33.2% reduction in the percentage of predicted FVC between the 
control group and those in the bilateral DPT group.
A number of previous studies have investigated the respiratory 
impairment caused by DPT.1,8,12–17 However, the reliance on a 
chest radiograph to make the initial diagnosis has prevented anal-
ysis of individuals in whom there is DPT without obliteration of the 
CPA. For instance, Singh et al predicate their hypothesis that DPT 
impacts lung function by involvement of the diaphragm based on 
a study of seven patients all of whom had CPA obliteration.16 More 
recently, a study by Ameille et al, designed to evaluate the impact 
of size-based criteria for DPT vs involvement of the costophrenic 
recess (n = 287) identified the poor correlation of size criteria on 
chest radiography with lung function.11 However, assessment of 
the true extent using chest radiography alone is very problematic 
and only allows for accurate craniocaudal extent of laterally sited 
pleural thickening. In this study, the authors acknowledge the 
superiority of CT over chest radiographs but aimed to provide data 
applicable to the current guidelines, which favour radiographs.11 
The relative merits of CT-based size criteria over chest radiograph 
measurements is supported in a study by Fujimoto et al14 in which 
they found that size criteria using CT were predictive of respiratory 
deficit. Finally, a CT-based study by Copley et al8 demonstrated that 
pulmonary function deficits are proportional to the extent of DPT 
(defined in their cohort only as pleural thickening with a tapering 
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Figure 5. Trend of percentage of  predicted TLC  by 
group. CPA, costophrenic angle; DPT, diffuse pleural thicken-
ing; TLC, total lung capacity.
Figure 6. Mean TLC % predicted with confidence intervals
margin; 5 out of 50 patients had DPT without obliteration of the 
CPA). A further shortcoming of the chest radiograph to diagnose 
DPT is the inability to discriminate between other pathologies that 
may mimic DPT. In our study, we excluded 16 patients with pleural 
effusions; six of these patients had small effusions that could easily 
be interpreted as pleural thickening on the chest radiograph in the 
absence of contemporaneous CT imaging.
It is unclear how the arbitrary size-based CT definition proposed 
by Lynch et al was reached;6 however, it remains widely cited in 
leading reviews and texts.18 In our study, we have refined the defi-
nition in order to exclude patients with confluent pleural plaques in 
two ways. First, the morphology of pleural thickening was assessed. 
Tapered margins are a feature of DPT compared with the shoul-
dered margins of pleural plaques.8 Second, the presence of folded 
lung or pleuroparenchymal bands was assessed confirming that 
there was fibrosis of the visceral pleura rather than thickening of 
the parietal pleura alone.19
The mechanism of breathlessness in DPT remains contro-
versial. The reduction in the lung function vital capacity 
has been attributed to the reduced expansion of the lower 
thoracic rib cage and reduced axial height of the rib cage.16 
If the extent of the pleural thickening is significant, this in 
itself can cause restriction in the movement of the chest wall, 
a “lung en cuirasse” effect, despite the lack of extension over 
the diaphragm.20 In our study, we clearly demonstrate a signif-
icant difference in the predicted FVC and TLC in those with 
DPT but no CPA obliteration  (Figure 4 and 6) when compared 
with a matched control group comprising  patients  who have 
evidence of previous asbestos exposure—pleural plaques, but 
no other underlying pleuroparenchymal pathology. The trend 
of the lung function demonstrates that patients with DPT but 
no CPA obliteration lie between the control group and the 
unilateral DPT group.
The current definitions of DPT based on chest radiography 
have been a pragmatic choice reflecting worldwide availability 
of this low-radiation, cost-effective technique. They also reflect 
the high level of interobserver agreement in defining obliteration 
of the CPA as opposed to size criteria on chest radiography.7,11 
However, CT is now acknowledged as the gold standard for 
imaging the pleura. The Industrial Injuries Disablement Benefit 
currently uses the ILO’s classification of pneumoconiosis criteria 
when assessing patients’ eligibility for compensation, which 
requires “obliteration of the CP angle”.4 This study highlights 
that there is a group of patients with DPT who do not meet the 
current definitions laid out by the ILO, yet have significant respi-
ratory impairment.
Particular care must be taken during the initial assessment of 
patients with new DPT. Many of these cases will require a confir-
matory pleural biopsy to exclude underlying malignancy, partic-
ularly in the presence of concerning symptoms such as chest 
wall pain or weight loss, at presentation. Six patients (6/64, 9%) 
in our study who were referred with pleural thickening were 
discovered to have pleural malignancy after initial investigations 
(5 mesotheliomas and 1 metastatic breast cancer). Our standard 
operative procedure for DPT follow-up is a minimum of 2  years 
with interval CT imaging at 6, 12 and 24 months. This allows us 
to assess any progression and exclude a developing underlying 
pleural malignancy.
Our study is not without limitations. First, although this is the 
largest published series of patients with DPT on CT imaging, 
the number of subjects in each subgroup remains small. Second, 
although every effort was made to match the groups for age, BMI 
and cumulative smoking history, we were unable to adjust for the 
extent of emphysema present on CT imaging. We did, however, 
manage to exclude any patients with a coexisting pleural effusion 
or underlying pulmonary fibrosis.
In summary, this is the largest published series investigating the 
effects of varying distributions of DPT on respiratory function. 
Our study shows that there is a restrictive defect in the lung func-
tion of patients with DPT who have no CPA obliteration on chest 
radiograph compared with a matched control group. Those with 
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bilateral and unilateral pleural thickening by size criteria on CT 
also had significant reductions in their lung function tests (FVC 
and TLC) compared with the plaque only group, with bilateral 
DPT being the most disabling condition.
